Hepatitis C in Pregnancy in the Era of Direct-acting Antiviral Treatment: Potential Benefits of Universal Screening and Antepartum Therapy

被引：18

作者：

Bernstein, Helene B. ^{[1
,2
]}

Dunkelberg, Jeffrey C. ^{[3
]}

Leslie, Kimberly K. ^{[4
]}

机构：

[1] SUNY Upstate Med Univ, Dept Obstet & Gynecol, Syracuse, NY 13210 USA

[2] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA

[3] Univ Iowa, Dept Internal Med, Div Gastroenterol & Hepatol, Iowa City, IA 52242 USA

[4] Univ Iowa, Dept Obstet & Gynecol, Div Maternal Fetal Med, Carver Coll Med, Iowa City, IA 52242 USA

来源：

CLINICAL OBSTETRICS AND GYNECOLOGY | 2018年 / 61卷 / 01期

关键词：

hepatitis C; pregnancy; antiviral agents; antepartum therapy; universal screening; VERTICAL TRANSMISSION; PATIENT POPULATIONS; CLINICAL-RESEARCH; VIRUS-INFECTION; WOMEN; RISK; PREVENTION; DAAS;

D O I：

10.1097/GRF.0000000000000345

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Hepatitis C in pregnancy is on the rise, and new direct-acting antiviral agents are available that cure the disease. Published recommendations need to be reviewed and clinically evaluated for the care of pregnant women who are at risk for or have chronic hepatitis C. Available evidence and some of the medical and ethical reasons to consider universal screening and antepartum therapy for hepatitis C during pregnancy are presented. Universal screening and proactive treatment during pregnancy is on the horizon, and these measures should be quickly evaluated for safety and implemented if appropriate.

引用

页码：146 / 156

页数：11

共 50 条

[21] Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infection
Feld, Jordan J.
Jacobson, Ira M.
Sulkowski, Mark S.
Poordad, Fred
Tatsch, Fernando
Pawlotsky, Jean-Michel
LIVER INTERNATIONAL, 2017, 37 (01) : 5 - 18
[22] Hepatitis C virus and its cutaneous manifestations: treatment in the direct-acting antiviral era
Wiznia, L. E.
Laird, M. E.
Franks, A. G., Jr.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (08) : 1260 - 1270
[23] Simplified diagnostic monitoring for hepatitis C, in the new era of direct-acting antiviral treatment
Cohn, Jennifer
Roberts, Teri
Amorosa, Valerianna
Lemoine, Maud
Hill, Andrew
CURRENT OPINION IN HIV AND AIDS, 2015, 10 (05) : 369 - 373
[24] Cost Effectiveness of Universal Screening for Hepatitis C Virus Infection in the Era of Direct-Acting, Pangenotypic Treatment Regimens
Eckman, Mark H.
Ward, John W.
Sherman, Kenneth E.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (05) : 930 - +
[25] Treating paediatric hepatitis C in the era of direct-acting antiviral agents
Alqahtani, Saleh A.
Colombo, Massimo G.
LIVER INTERNATIONAL, 2021, 41 (06) : 1189 - 1200
[26] Hepatitis C virus infection in children in the era of direct-acting antiviral
Pawlowska, Malgorzata
Sobolewska-Pilarczyk, Malgorzata
Domagalski, Krzysztof
WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (24) : 2555 - 2566
[27] Rheumatologic manifestations of hepatitis C in the era of direct-acting antiviral agents
Priora, Marta
Realmuto, Cristina
Parisi, Simone
Ditto, Maria C.
Borrelli, Richard
Peroni, Clara L.
Lagana, Angela
Fusaro, Enrico
MINERVA GASTROENTEROLOGICA E DIETOLOGICA, 2020, 66 (03) : 280 - 289
[28] Microbiota and hepatitis C virus in the era of direct-acting antiviral agents
Pinchera, Biagio
Moriello, Nicola Schiano
Buonomo, Antonio Riccardo
Zappulo, Emanuela
Viceconte, Giulio
Villari, Riccardo
Gentile, Ivan
MICROBIAL PATHOGENESIS, 2023, 175
[29] Hepatitis C Virus Viral Assays in the Direct-Acting Antiviral Era
Vierling, John M.
CLINICS IN LIVER DISEASE, 2013, 17 (01) : 27 - +
[30] Primary Care Physician Perspectives on Hepatitis C Management in the Era of Direct-Acting Antiviral Therapy
Mary Thomson
Monica A. Konerman
Hetal Choxi
Anna S. F. Lok
Digestive Diseases and Sciences, 2016, 61 : 3460 - 3468

← 1 2 3 4 5 →